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Palliative care planning for nursing home residents with advanced dementia is often subopti-
mal. This study compared effects of facilitated case conferencing (FCC) with usual care
(UC) on end-of-life care.
Methods
A two arm parallel cluster randomised controlled trial was conducted. The sample included
people with advanced dementia from 20 Australian nursing homes and their families and
professional caregivers. In each intervention nursing home (n = 10), Palliative Care Planning
Coordinators (PCPCs) facilitated family case conferences and trained staff in person-cen-
tred palliative care for 16 hours per week over 18 months. The primary outcome was family-
rated quality of end-of-life care (End-of-Life Dementia [EOLD] Scales). Secondary out-
comes included nurse-rated EOLD scales, resident quality of life (Quality of Life in Late-
stage Dementia [QUALID]) and quality of care over the last month of life (pharmacological/
non-pharmacological palliative strategies, hospitalization or inappropriate interventions).
Results
Two-hundred-eighty-six people with advanced dementia took part but only 131 died (64 in
UC and 67 in FCC which was fewer than anticipated), rendering the primary analysis under-
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powered with no group effect seen in EOLD scales. Significant differences in pharmacologi-
cal (P < 0.01) and non-pharmacological (P < 0.05) palliative management in last month of
life were seen. Intercurrent illness was associated with lower family-rated EOLD Satisfaction
with Care (coefficient 2.97, P < 0.05) and lower staff-rated EOLD Comfort Assessment with
Dying (coefficient 4.37, P < 0.01). Per protocol analyses showed positive relationships
between EOLD and staff hours to bed ratios, proportion of residents with dementia and staff
attitudes.
Conclusion
FCC facilitates a palliative approach to care. Future trials of case conferencing should con-
sider outcomes and processes regarding decision making and planning for anticipated
events and acute illness.
Trial registration
Australian New Zealand Clinical Trial Registry ACTRN12612001164886
Background
Care in advanced dementia requires a palliative approach focused on quality of life (QOL) [1–
4]. Nursing home residents with advanced dementia often receive suboptimal palliation due to
limited staff awareness and training [2, 5–14]. Communication between staff, health services
and families (including surrogate decision-makers) addressing palliative care needs is often
poor [6, 7]. Decisions include whether hospital transfers and acute interventions such as intra-
venous antibiotics will offer net benefit versus detriment to QOL [8, 9, 12, 15–18]. Surrogates
should be involved in symptom management decisions and care planning, and provide the
personal context [7, 10, 14].
Case conferencing brings together health professionals and other surrogate decision-mak-
ers to build consensus on goals of care and appropriate steps for current management and
advance care planning. Case conferencing shows promise for improving symptom manage-
ment in people with dementia living in nursing homes but systematic reviews have highlighted
methodological weaknesses in the evidence base [19, 20]. Evidence from randomised con-
trolled trials (RCTs) in the community palliative care setting is more compelling with better
maintenance of physical and mental health [21] and decreased hospitalization seen, [22] pro-
vided the process is facilitated by appropriate training and organizational support [23–25].
The current study compared the efficacy of facilitated case conferencing versus usual care




A cluster RCT design was used because the intervention aimed to change the approach to
dementia palliative care across nursing homes and randomizing individual residents or staff
members would have resulted in contamination. The parallel cluster RCT design is described
in a published protocol [26] (see also S1 File), and was conducted over a predefined study
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period of 18 months between February 2013 to December 2014. Human Research Ethics Com-
mittees of the University of NSW, University of Technology Sydney, Queensland University of
Technology approved the trial. This paper focuses on the study’s first aim, namely to compare
the efficacy of a facilitated approach to family case conferencing with usual care. As such, it
focuses on data relevant to evaluating quality of end of life (EOL) care for participants who
died during the study period. Data relevant to understanding processes influencing implemen-
tation and evaluating cost-effectiveness will be reported in other papers. Details are reported
according to the Consolidated Standards of Reporting Trials Checklist for Cluster Randomised
Controlled Trials (see S1 Table).
Randomization and blinding
The study’s statistician (GL) generated a block randomization schedule using a computer-gen-
erated allocation sequence, and allocated nursing homes to each arm after collection of institu-
tional-level baseline data, stratifying by organizational affiliation. Due to the system-level
nature of the intervention, participating investigators, project managers and nursing home
managers could not be blinded to the evaluative aim of the research or to nursing home alloca-
tion. Staff, residents and families at each nursing home were blinded to the evaluative aim of
the study, but those in nursing homes allocated to the intervention arm were aware of associ-
ated changes to practice (see below). Research staff were blinded to the evaluative aim of the
study and collected data from nursing homes in only one arm to reduce the likelihood they
would notice systematic differences in practice.
Sites
Sites were 20 nursing homes in two major Australian cities meeting the following criteria: 1)
100 beds, 2)50% people with dementia, and 3) designated as facility providing intensive
level of nursing home care. Nursing homes were identified from an Australian government
website list [27] and approached in alphabetical order to minimise selection bias.
Participants
The MORECare initiative[28] informed target participants, namely people with advanced
dementia living in residential care (‘residents’) where surrogate decision-maker involvement
for palliative care planning is needed. Potentially eligible residents were identified by nursing
home managers and screened by the study team. Residents needed to have dementia docu-
mented in nursing home records and advanced dementia as determined by scores on the: 1)
Functional Assessment Staging Tool (FAST)[29] in dementia (6a, stable for 1 month), and 2)
Australia–modified Karnofsky Performance Status (AKPS) [30]50. These criteria were cho-
sen because a FAST stage 7c combined with functional dependency (measured here by the
AKPS) is predictive of an average survival of<6 months, and the study’s primary endpoint
focused on end of life care [31]. A family member with legal authority provided written
informed consent on behalf of the resident. Either the same or another family member
involved in making decisions about the resident’s care also gave written informed consent for
their own participation in the study. Written informed consent was collected after randomiza-
tion of nursing homes.
All permanent registered and enrolled nurses and care assistants of participating nursing
homes were invited to join the study via staff meeting presentations and email circulars and
gave informed consent after randomization of nursing homes.
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Intervention
Facilitated case conferencing (FCC) was compared with usual care (UC) as follows.
Facilitated case conferencing (FCC). Theoretical frameworks underpinning FCC
included the expected trajectory of advanced dementia [2] and evidence-based strategies for
organizational culture change (clinical leadership [32] and train-the-trainer[33]). A Registered
Nurse was trained as a Palliative Care Planning Coordinator (PCPC) in each nursing home
working for 2 days per week or equivalent to: 1) identify residents with advanced dementia
likely to benefit from a case conference; 2) organise, set an agenda, chair and document case
conferences with optimal participation by family, multi-disciplinary nursing home staff and
external health professionals (e.g. General Practitioner’s (GP’s)); 3) develop and oversee imple-
mentation of palliative care plans; and 4) train nursing and direct care staff in person-centred
palliative care. The key features of the case conference model were: use of pre-defined specific
clinical triggers for a case conference; used a shared agenda setting model where the resident,
their family and all multidisciplinary staff could specify a priori areas for discussion; required
attendance of the resident and/or their substitute decision maker or family member(s); was
facilitated by the PCPC to ensure optimal participation of attendees; and was followed by a
communication strategy to summarise actions and plan arising from the case conference. Dis-
cussion topics were not limited and were individualised to what was seen as important for the
resident; and could include care planning, current and future treatment decision making,
information sharing, meeting resident preferences or needs and advance care planning.
Usual care (UC). In nursing homes randomised to UC, no staff education, training or
support was provided. No restrictions were placed on nursing homes’ education programme,
or approach to care planning and decision-making.
Data collection
Details of baseline, process and outcome data are provided in the published protocol [26]. Res-
ident-level measures used validated measures in advanced dementia which perform well with
surrogate report. Data on resident and nursing home variables likely to influence EOL care
[34], and FCC fidelity was also collected. All nurse and family-rated measures were collected
via face-to-face or telephone interview with the research team.
The primary outcome was family-rated EOL care (End of Life in Dementia (EOLD) Scales)
[35] optimally assessed four to six weeks following the residents death: a) symptom-related
comfort during the last 7 days of life (Comfort Assessment in Dying with Dementia; CAD–
EOLD); b) symptom management in the last 90 days of life (Symptom Management at the
End of Life in Dementia; SM–EOLD); and c) family or caregiver’s satisfaction with care during
the last 90 days of life (Satisfaction With Care at the End of Life in Dementia; SWC–EOLD).
Resident-level secondary outcomes were nurse-rated CAD-EOLD and SM-EOLD ratings as
soon as possible following the resident’s death; nurse-rated QOL three monthly (Quality of
Life in Late-stage Dementia (QUALID) Scale [36]), and symptoms and care in the last month
of life extracted from nursing home and medical records (symptom control medication [e.g.
analgesics] versus diagnosis oriented [e.g. antibiotics, anti-epileptics, anxiolytics, steroids]
commencement, cessation and dose alteration; non-pharmacological strategies [e.g. family
attendance, body positioning]; symptom assessment frequency; acute care episodes and poten-
tially inappropriate non-palliative interventions [ventilation, resuscitation, enteral feeding,
intravenous antibiotics and fluids, dialysis, transfusion, oxygen and surgery). Comorbidities
were collected from the resident record classified as life threatening (e.g. cancer, organ failure,
neurological), disabling (e.g. hearing/vision, musculoskeletal) or inter-current acute (e.g.
infections).
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Nursing home variables were: staff attitudes to, knowledge of and confidence in providing
palliative care to people with advanced dementia (Palliative Care for Advanced Dementia
[qPAD] [37]); ratio of nursing staff hours to beds; and proportion of residents with dementia.
Fidelity to protocol (intervention ‘dose’) at the resident level was collected for use in per
protocol (PP) analyses, but could not be measured as planned [26] as many UC nursing homes
did not routinely collect detailed information about case conferences (e.g. triggers, attendance,
issues discussed), and encouraging this data collection may have led to contamination. A sim-
pler dose measure was used, namely whether or not participating residents received a case
conference during their time in the study. Dose at the nursing home level consisted of four
indicators concerning the extent to which PCPCs: 1) were able to work 2 days per week, 2)
were supported by managers, 3) fulfilled expectations outlined in training, and 4) diffused
their role among other staff. Each indicator was scored 0, 1 or 2, with 0 representing a lesser
extent, 1 a moderate extent and 2 a large extent.
Sample size
Assuming an intracluster correlation coefficient (ICC) of 0.05 (estimated from unpublished
data sourced from Dutch nursing homes), a sample size of 8 clusters per arm with 15 residents
(who died during the study period and for whom EOL outcomes would be available) per clus-
ter (i.e. N = 240 in total), was considered adequate to identify a between-arm difference of 0.5
standard deviation (SD) on the EOLD scale with a two-sided 5% significance level and power
of 80%. We conservatively anticipated a 10% resident dropout rate (e.g. withdrawal of consent
to participate in the study; resident moved to another nursing home). Allowing for this, a
recruitment target of 272 people with advanced dementia (17 per site) was set. This calculation
incorporated an estimate that almost all people (98%) meeting the inclusion criteria would die
(and so yield data on EOL care) within the study period (<18 months) based on review of
dementia- specific mortality data from local nursing homes and evidence from the literature
relating to prognostic variables referred to above [31, 38]. In other words, with a 10% with-
drawal rate and 2% survival rate, of 272 participants we would expect 27 to withdraw, and of
the remaining 245, five to survive to the end of the study period, resulting in a total sample size
of 240 available for analysis.
Analysis
Between-arm differences at baseline in resident and nursing home characteristics and second-
ary outcomes were analysed using two-tailed t-tests for continuous variables where the distri-
bution was normal or the Mann-Whitney U z-test where distribution was significantly
skewed. Chi-square tests were used to determine whether differences were significant on cate-
gorical variables.
Analyses of primary and secondary outcomes were on an intention to treat (ITT) basis.
Generalised linear mixed models (GLMMs) were used to analyse the impact of the interven-
tion on EOL care (EOLD) and quality of life (QUALID; last measurement during the 90 days
prior to resident death). GLMMs were run without adjustment to the dependent variables, and
following an evaluation of model best fit using information criteria, were conducted assuming
normal distributions with identity links. Residual plots were visually inspected to ensure there
were no substantial deviations from normality or homoscedasticity. GLMMs allow for the
inclusion of fixed and random effects in the model. These models account for nested sources
of variability in data, such as when residents with different characteristics are clustered within
nursing homes. In these models, the nursing home was included as a random effect, account-
ing for intra cluster-correlations in the sample and consequently producing better fixed-effect
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estimates. While some nursing home level variables were included in the models, the inclusion
of a random effect allows for other unmeasured nursing home level effects. In all models, there
were resident-level control variables (comorbidities: presence or absence of a disabling condi-
tion, an inter-current acute condition, or a life-threatening condition) and nursing home-level
control variables (proportion of residents with dementia; baseline ratio of nursing staff hours
to bed number; and median staff qPAD Knowledge Test and Attitude Scale scores). These
models were rerun in a series of Per Protocol (PP) analyses, excluding nursing homes from the
FCC arm that did not implement the intervention to any degree planned (i.e. had a score of ‘0’
on all four nursing home dose variables), and including the resident-level dose variable of
whether or not a case conference was received.
Statistical analyses were conducted using IBM SPSS Statistics version 22 (IBM Corp.,
Armonk, NY). Alpha, the significance level threshold, was set at 0.05 for all statistical tests.
Results
Forty-nine nursing homes were approached to recruit the 20 needed (Fig 1). Reasons for
declining to participate included a lack of interest in research, other research projects or confi-
dence in their case conferencing and palliative care programs. Due to difficulties recruiting
facilities, three facilities were included who had less than 100 beds (two UC with 46 and 88
beds; one FCC with 75 beds). Three hundred and nineteen residents were assessed for eligibil-
ity, with 25 not eligible. Informed consent was obtained for 294 residents, and four died prior
to the intervention period commencing and four withdrew. The baseline sample comprised
130 residents (UC facilities) and 156 residents (FCC facilities). During the study, 131 (46%)
participants died, 64 in UC and 67 in FCC. Median time to death was 7 months (inter-quartile
range [IQR] 9), with no difference between the UC and FCC arms (P = 0.27).
Baseline characteristics of the 20 nursing homes and 131 people who died during the study
are in Table 1. Participants in FCC and UC arms had similar baseline characteristics, though
FCC participants were more likely to be born in Australia and were visited less frequently.
FCC and UC nursing homes were similar in proportion of people with dementia during the
previous 3 months and nursing staff hours to bed ratios. However, nurses and care assistants
in the FCC arm had significantly higher baseline qPAD knowledge scores, indicating a greater
knowledge of palliative care for advanced dementia.
End of life outcomes
Family-reported EOL outcomes were available for approximately three-quarters of the partici-
pants who died (76%, 99/131), with no systematic differences in demographic characteristics for
people with or without a family EOLD report. Family-rated EOLD measures were completed at
a median 7.3 weeks (IQR 5.7; range 2.7 to 24 weeks) and nurse reports at a median 2.4 weeks
(IQR 4.0; range 0 to 22 weeks); Table 2 outlines summary statistics. There was no significant
group effect on the EOLD scales in any of the models (i.e. family-rated CAD-EOLD, SM-EOLD
and SWC-EOLD or nurse-rated CAD-EOLD and SM-EOLD).
ICCs for the CAD-EOLD and SWC-EOLD were less than assumed (0.008 and negative
respectively) whereas for SM-EOLD the ICC was greater than assumed (0.124). Staff-reported
EOLD were missing for four people. There was no significant group effect on the EOLD scales
in any of the models. In the ITT models, presence of inter-current acute comorbidity was asso-
ciated with lower family rated satisfaction with care (SWC-EOLD) and poorer staff rated com-
fort level (CAD-EOLD) (see Table 3).
PP analyses indicated positive associations between family-rated EOLD satisfaction with
care and better staff attitudes, increased ratios of nursing staff hours to beds, and lower
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proportions of people with dementia in the nursing home, in addition to absence of inter-cur-
rent acute comorbidities (see Table 4). Symptom management was rated as poorer by staff for
those participants who had a case conference, regardless of treatment arm. In the FCC arm,
69% (n = 46/67) of residents who died received at least one case conference compared with
44% in the UC arm (n = 28/64) (P = 0.004). Staff ratings of CAD-EOLD were higher in nursing
homes with higher proportions of people with dementia. CAD-EOLD was also rated as lower
in people with a comorbid disability or with an inter-current acute condition.
Fig 1. Study flowchart for IDEAL study residents included in EOLD analysis (N = 131). † Original nursing home eligibility criteria
were amended, allowing three facilities with bed counts <100 to be included.
https://doi.org/10.1371/journal.pone.0181020.g001
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Ratings of the person’s quality of life (QUALID) during the 90 days prior to death were sig-
nificantly associated with staff qPAD knowledge in the ITT model, with better quality of life
being associated with nursing homes with higher staff knowledge scores (coefficient -1.04,
P = 0.036). This effect was not observed in the PP model.
Symptoms and care during the last month of life
The prevalence of symptoms observed to be documented in nursing progress notes during the
month prior to death differed between the arms, with the FCC arm significantly more likely
than UC to have documentation of pain/discomfort (P = 0.04), restlessness (P = 0.02), constipa-
tion (P = 0.002) skin tears (P = 0.005) and other symptoms (including being resistive to care,
agitation, pressure areas, wounds, respiratory infection and chest rattles) (P< 0.001). Symp-
toms not observed more commonly in one arm versus the other included difficulty swallowing/








Proportion of residents with dementia, median (IQR) 67.5 (24) 67.5 (28) 67.5 (24)
Nursing staff hours to bed ratio, median (IQR) 20.7 (8.9) 21.2 (4.2) 21 (5.9)
Questionnaire on Palliative care for Advanced Dementia
staff median (IQR)
staff Knowledge Test 14 (3) 16 (4)‡ 15 (4)
staff Attitude Scale 48 (8) 48 (8) 48 (8)
Participants at baseline
Age, mean ± SD 85.8 ± 8.2 84.7 ± 7.9 85.3 ± 8.0
range 57–101 60–104 57–104
Female, n (%) 37 (58) 41 (61) 78 (60)
Born in Australia, n (%) 33 (52) 47 (70)† 80 (61)
Length of stay (months), median (IQR) 20.5 (43) 29 (41) 26 (42)
Time to death (months), median (IQR) 8 (8) 6 (10) 7 (9)
Died in nursing home, n (%) 55 (89) 58 (88) 113 (88)
Visitor frequency, n (%)
Daily or more 22 (34) 13 (19)† 35 (27)
Between daily-weekly 27 (42) 15 (22) 42 (32)
Weekly 6 (9) 19 (28) 25 (19)
Fortnightly or less 9 (14) 20 (30) 29 (22)
Functional Assessment Staging Tool, n (%)
level 6 13 (20) 19 (28) 32 (24)
level 7 51 (80) 48 (72) 99 (76)
Australian-modified Karnofsky Performance Status, n (%)
20: totally bedfast 18 (28) 12 (18) 30 (23)
30: almost completely bedfast 14 (22) 8 (12) 22 (17)
40: in bed >50% of the time 10 (16) 20 (30) 30 (23)
50: considerable assistance 22 (34) 27 (40) 49 (37)
Quality of Life in Late Stage Dementia, median (IQR) 25 (13) 25 (9) 25 (10)
FCC, facilitated case conferencing; IQR, inter-quartile range; SD, standard deviation
† P < 0.05
‡ P < 0.001
https://doi.org/10.1371/journal.pone.0181020.t001
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eating/drinking, drowsiness, breathlessness, coughing, choking/gurgling, vomiting, fear or anxi-
ety, diarrhoea and depression (P> 0.05).







Family-rated EOLD care, mean (SD)
CAD-EOLD 35.5 (5.9) 34.7 (5.9) 35.1 (5.9)
range (possible 14–42) 18–42 15–42 15–42
SM-EOLD 31.7 (7.4) 29.0 (9.5) 30.3 (8.6)
range (possible 0–45) 13–44 9–45 9–45
SWC-EOLD 30.3 (4.2) 31.0 (5.3) 30.7 (4.8)
range (possible 10–40) 20–40 20–40 20–40
Nurse-rated EOLD care, mean (SD)
CAD-EOLD 33.3 (5.7) 32.1 (6.1) 32.7 (5.9)
range (possible 14–42) 23–42 16–42 16–42
SM-EOLD 23.2 (8.3) 22.4 (9.6) 22.7 (9.0)
range (possible 0–45) 4–40 6–40 4–40
† missing items varied between 7.1 and 16.2% for family-rated EOLD scores and between 1.6% and 8.7% for nurse-rated EOLD scores. CAD-EOLD,
Comfort Assessment in Dying with Dementia (higher scores, more comfort); SM-EOLD, Symptom Management at the End of Life in Dementia (higher
scores lower symptom frequency); SWC-EOLD, Satisfaction With Care at the End of Life in Dementia (higher scores, greater satisfaction).
https://doi.org/10.1371/journal.pone.0181020.t002





Coefficient F-test Coefficient F-test
Arm
Usual care .13 .91 1.68 .13
FCC 0 0
Proportion dementia -.01 .76 .05 .20
qPAD knowledge .35 .44 .48 .25
qPAD attitude .29 .20 -.05 .80
Staff hours to bed ratio .07 .61 -.02 .87
Comorbidity:
Disability
Absent .80 .46 1.98 .07
Present 0 0
Inter-current acute
Absent 2.97 .030† 4.37 .003‡
Present 0 0
Life threatening
Absent -.87 .41 -.60 .59
Present 0 0
FCC, facilitated case conferencing; qPAD, Questionnaire on Palliative care for Advanced Dementia
N.B. ‘F-test’ refers to the P-value associated with the F test
† Poorer family rated satisfaction with care in those with inter-current acute comorbidity
‡ Poorer staff rated comfort assessment in dying in those with inter-current acute comorbidity
https://doi.org/10.1371/journal.pone.0181020.t003
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Equal numbers (47%) in FCC (31/66) and UC (n = 29/62) had formal pain assessments, but
more documentation of pain assessment frequency was seen in the FCC arm (97% (30/31))
than UC (79% (23/29)). Pain assessments were daily or more often in 40% of the FCC partici-
pants (12/30) compared with 17% (n = 4/23) of those in UC (P = 0.08).
The majority of participants died in the nursing home in both arms. Pharmacological and
non-pharmacological changes to management, and physician input during the month prior to
death were significantly more common in the FCC arm (see Table 5). Medication initiations
in FCC were more frequently symptom-oriented (e.g. analgesics, laxatives) than diagnosis-ori-
ented (e.g. antibiotics, anti-epileptics, anxiolytics, steroids).
Discussion
This RCT evaluated EOL outcomes of facilitated family case conferencing in advanced demen-
tia from perspectives of EOL care received (satisfaction) and resident outcomes (comfort, qual-
ity of life and quality of dying) [39]. While the study recruited sufficient participants overall, a
lower than estimated mortality rate meant the participants with primary outcome data (after







Coefficient F-test Coefficient F-test Coefficient F-test
Arm
Usual care 1.54 .19 -.20 .93 .58 .63
FCC 0 0 0
Case conference
Absent -1.13 .34 4.37 .023---P 1.78 .14
Present 0 0 0
Proportion dementia -.10 .035† .07 .41 .09 .050†
qPAD knowledge .04 .93 .68 .38 .76 .08
qPAD attitude .47 .029‡ .04 .92 -.16 .45
Staff hours to bed ratio .52 .012‡ -.03 .93 -.29 .15
Comorbidity:
Disability
Absent 1.13 .28 3.22 .06 2.16 .043‡
Present 0 0 0
Intercurrent acute
Absent 3.31 .014‡ 3.50 .12 4.07 .004‡
Present 0 0 0
Life threatening
Absent -.95 .36 -.83 .62 -.57 .60
Present 0 0 0
N.B. ‘F-test’ refers to the P-value associated with the F test
FCC, facilitated case conferencing; qPAD, Questionnaire on Palliative care for Advanced Dementia
† Better family rated satisfaction with care in nursing homes with lower proportions of residents with dementia; better staff rated comfort assessment in
dying in nursing homes with higher proportions of residents with dementia.
‡ Higher family rated satisfaction with care in nursing homes with more positive staff attitudes, more staff hours per bed, and in residents without an inter-
current acute comorbidity; higher staff rated comfort assessment in dying in people without a comorbid disability and in residents without an inter-current
acute comorbidity
---P Absence of a case conference was associated with higher staff ratings of symptom management
https://doi.org/10.1371/journal.pone.0181020.t004
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death) did not meet target sample size. Although no significant intervention effects were
observed on EOL outcomes or QOL, management was more consistent with a palliative
approach in FCC.
Higher rates of nurse-documented pain and restlessness, and more frequent pain assess-
ment, which are less readily observed and under-reported symptoms[14], suggest increased
awareness of symptoms as a result of FCC. Staff in both arms of the study tended to perceive
symptom management as poorer for residents who had a case conference than those who
didn’t, suggests case conferences foster proactive identification of symptoms.
Resident and nursing home variables are also informative in understanding factors associ-
ated with better EOL care. Inter-current acute comorbidities associated with lower family rat-
ing of satisfaction with care and lower nurse-ratings of comfort, highlights the need to plan
care not only for expected gradual decline and the last hours to days of life, but also for antici-
pated acute illness, comorbidities and “crisis events” (e.g. aspiration pneumonia). Case confer-
ences have also been used in nursing homes for other decision-making (e.g. behavioral and
psychological symptoms of dementia) [40], and integration of these models is important.
Quality of EOL care was associated with proportion of people with dementia, higher nursing
and direct care staff hours and attitudes towards advanced dementia, consistent with previous
evidence that being cared for in a dementia unit reduces likelihood of hospitalisation [41].
However, it is less clear why these relationships were observed only in the PP analyses or why
staff knowledge about advanced dementia was not predictive of EOL care given its association
with QOL in the last 90 days of life.
Table 5. Care in the last month of life (N = 131).






Died in nursing home, n (%) 55 (89) 58 (88) 113 (88)
Medication changes, n (%) 45 (75) 58 (94)---P 103 (84)
Symptom-oriented, n (%) 19 (42) 48 (83) 67 (51)
Non-symptom-oriented, n (%) 4 (9) 5 (9) 9 (7)
No change, n (%) 22 (49) 5 (9) 27 (21)
Non-pharmacological management, n (%) 42 (68) 56 (85)† 98 (77)
At least one hospital admission, n (%) 11 (18) 13 (19) 24 (19)
Hospital length of stay, median (IQR) 5 (5) 2 (4) 4 (5)
ED presentation without hospital admission, n (%) 6 (10) 6 (9) 12 (9)
Input from health professionals, n (%) 37 (60) 39 (59) 76 (59)
Medical 21 (34) 35 (53)† 56 (44)
Nursing 2 (3) 3 (5) 5 (4)
Allied health 24 (39) 25 (38) 49 (38)
Other 12 (19) 15 (23) 27 (21)
Non-palliative interventions, n (%) 20 (33) 26 (39) 46 (36)
† P < 0.05
---P P < .01
* data missing (N ranges from 122 to 129)
ED, emergency department; FCC, facilitated case conferencing; IQR, interquartile range
Non-pharmacological interventions included changes to the physical environment, activities, positioning, family presence, pastoral support, lighting or noise
levels, music or move to single room
Non-palliative interventions included: oxygen, subcutaneous fluids, intravenous fluids, intravenous antibiotics, surgery and ‘other’ (e.g. vaccinations;
indwelling catheter).
https://doi.org/10.1371/journal.pone.0181020.t005
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Our study has a number of limitations. The inclusion criteria aimed to capture a group of
residents with advanced dementia with a high mortality rate. However, even with a participant
population where nearly 40% were totally or completely bedfast (compared to 9% in the larg-
est-scale study to date, the CASCADE [Choices, Attitudes, and Strategies for Care of Advanced
Dementia at the End-of-Life] Study [38]) and an 18 -month study period (compared with 12
months in the CASCADE Study), the mortality rate was only 46% (compared with 41% in the
CASCADE Study). The local Australian data we further relied on to estimate mortality identi-
fied a 50% mortality rate in high level care residents with all-stage dementia, but was not able
to distinguish mortality due to dementia versus other comorbid illnesses or limit to those with
advanced stage dementia only. We recommend that future studies should use more conserva-
tive estimates utilizing published mortality rates. We followed previous trials of case confer-
encing [42, 43] in taking a pragmatic approach aimed at improving external validity by
reflecting the diversity of current practice [44, 45]. While staff, residents and families at each
nursing home were blinded to the evaluative aim of the study, those in nursing homes in the
intervention arm were aware of the introduction of the PCPC role and changes in case confer-
encing and staff education and so may have been more inclined to report favourably on the
quality of palliative care offered as a result. Whilst we introduced measures to limit sampling
bias, it seems likely that participating nursing homes were more proactive in palliative care
and quality improvement than the sector average. With the exception of one US [46] and one
Dutch [47] study, mean scores for family and nurse ratings on the SWC-EOLD, SM-EOLD
and CAD-EOLD across both arms were either comparable with, or higher than, those reported
in the international literature [48–54], and hospitalization and potentially non-palliative inter-
ventions use were low [12, 43]. It is also possible that we did not control for important con-
founder, mediator or suppressor variables amongst the myriad resident, family and nursing
home factors that may have been influential [55]. Whilst the EOLD Scales have demonstrated
responsiveness in previous longitudinal research [56], their focus on end of life care may have
lacked sensitivity to complex interactions with nursing home, staff, and family characteristics;
missed benefits earlier in the person’s care, or failed to detect the surrogate decision-maker’s
perceived support and engagement in decisions and care choices. Also, timing of EOLD scale
administration occurred substantially later than the optimal window in many cases, risking a
recall bias of unknown direction and similar across both arms. Measurement of family experi-
ence, such as decisional conflict and bereavement, may also have been informative. Finally,
dose measurement failed to incorporate case conference details, PCPC motivation and adher-
ence to care plans, all of which may have affected EOL care. UC nursing homes can use more
informal means other than case conferencing to share decisions with families (i.e. one-to-one
conversations between nursing staff and families); such interactions where not captured in the
dose measure but may have positively influenced EOL care and family satisfaction. It should
also be noted that diagnosis-oriented medications are sometimes used with intent of symptom
alleviation (e.g. corticosteroids for breathlessness from respiratory conditions) which may
have led to underestimation of palliative pharmacological strategies.
Conclusion
This study is one of the few RCTs of palliative care interventions in nursing homes worldwide,
and appears to be the first to test efficacy of facilitated family case conferencing for people with
advanced dementia. The study’s primary endpoint of quality of EOL care was under-powered
and did not show evidence of effect. In spite of these limitations, a systematic approach to facil-
itating a palliative approach and skills enhancement drove improvements in care. Given the
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growing burden of dementia globally, these data will be formative in interventions aimed to
improving palliative care in nursing homes in the future.
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